A new set of evidence-based guidelines may help address CMS policies that severely restrict access to in-home noninvasive ventilation by patients with COPD.
David G. Hill and Jorge M. Mallea share their insight into stem cell therapy research for chronic obstructive pulmonary disease and provide an update on their pilot clinical trial.
Researchers assessed the occurrence and associated outcomes of frequent productive cough among patients with chronic obstructive lung disease and asthma.
In COPD, how does using single-inhaler triple therapy instead of multiple-inhaler triple therapy affect health care costs, mortality, and treatment adherence?
How does pulmonary rehabilitation of patients after COPD-related hospitalizations affect the overall cost of care and quality-adjusted life expectancy?